Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Equity Ratio (2016 - 2026)

Champions Oncology has reported Equity Ratio over the past 16 years, most recently at 0.15 for Q1 2026.

  • Quarterly results put Equity Ratio at 0.15 for Q1 2026, down 15.68% from a year ago — trailing twelve months through Jan 2026 was 0.15 (down 15.68% YoY), and the annual figure for FY2025 was 0.12, up 260.14%.
  • Equity Ratio for Q1 2026 was 0.15 at Champions Oncology, up from 0.14 in the prior quarter.
  • Over the last five years, Equity Ratio for CSBR hit a ceiling of 0.28 in Q1 2022 and a floor of 0.08 in Q1 2024.
  • Median Equity Ratio over the past 5 years was 0.14 (2023), compared with a mean of 0.12.
  • Biggest five-year swings in Equity Ratio: crashed 153.9% in 2024 and later skyrocketed 969.84% in 2025.
  • Champions Oncology's Equity Ratio stood at 0.25 in 2022, then crashed by 98.7% to 0.0 in 2023, then surged by 720.86% to 0.03 in 2024, then soared by 419.91% to 0.14 in 2025, then increased by 7.33% to 0.15 in 2026.
  • The last three reported values for Equity Ratio were 0.15 (Q1 2026), 0.14 (Q4 2025), and 0.12 (Q3 2025) per Business Quant data.